Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease
Genome-wide association studies (GWAS) have identified numerous susceptibility loci for Alzheimer’s disease (AD). However, utilizing GWAS and multi-omics data to identify high-confidence AD risk genes (ARGs) a...